Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: JHP who wrote (188948)	8/22/2002 9:09:11 AM
From: Knighty Tin	Respond to of 436258

John, Nah, the poor, undereducated U.S. Attorney in Philly is hoping to scare them into a face-saving settlement. And it is not just Medco, it's the entire industry. Medco is just the largest and the first focus. This weak letter was actually viewed as positive news yesterday, in that the govt. is finally stating its concerns instead of using vague "we dont' like you or the horse you rode in on" innuendoes in the media. The only real question is, are people who use PBMs getting lower priced prescriptions than those who don't? And the answer is overwhelmingly, yes. Is the industry competitive enough so nobody can grab pricing power. Yup. Are the cos. representing both the employer health care cos. and the drug cos.? Yes, and they admit it. That is the main bugaboo and there may be some changes there. I guess it could be illegal to get a patient drugs cheaper by pushing a drug cos' rebate program, but, for some reason, I think we want them to do that.